The effects of Transcutaneous electrical nerve stimulation on simulator sickness in healthy adults

Not Applicable

Completed

• Conditions: motion/simulator sickness; Alternative and Complementary Medicine - Other alternative and complementary medicine

• Registration Number: ACTRN12612001172897
• Lead Sponsor: Institute of Aerospace and Undersea medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-11-06
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 20

Inclusion Criteria

healthy, non-smoking, young male participants (age 20-40)

Exclusion Criteria

vestibular, visual, cardiovascular, respiratory, and gastrointestinal tract disorders.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Simulator sickness symptoms including sleepiness were evaluated with the Simulator Sickness Questionnaire (SSQ) and Visual Analogue Scales for evaluating Sleepiness Symptoms (VAS-SS)[before phase 1 and after phase 3 of the experiment];The d2 test, a standardized paper-and-pencil test, will be utilized to assess cognitive function, more specifically the visual attention[The d2 test will be tested before (during phase 1) and after simulator sickness induction (after phase 3) in each session]

Secondary Outcome Measures

Name	Time	Method
Salivary stress biomarkers' level (salivary alpha amylase activity and salivary cortisol concentrations) were evaluated.[before (during phase 1) and after simulator sickness induction (15 min and 30 min after phase 3) in each session.];heart rate and derived heart rate variability (HRV) were recorded and analyzed.[before (during phase 1) and after simulator sickness induction in each session.]